Funder
MRC, BBSRC, EPSRC: Pre-announcement: international collaboration to address antimicrobial resistance
Added date
18/11/2021
Closing date
08/03/2022
Call summary
This is a pre-announcement for the ‘Disrupting drug Resistance Using Innovative Design’ (DRUID) funding opportunity. This guidance gives all the information available so far.
The full details and application process will be available on the JPIAMR website. UK-based researchers will also need to submit a UK budget to UKRI. We will update this guidance with details of how to do this by the opening date (11 January 2022).
Scientific scope
Proposals should involve either:
- licensed antibiotics or antifungals
- agents in pre-clinical or early clinical development.
It could aim to:
- improve efficacy or specificity
- repurpose existing interventions
- optimise combinations of drugs or plant protection agents
- design and implement:
- new strategies
- innovative tools, including novel chemistry and new materials.
PI eligibility
Applicants need to be based at a research organisation eligible for MRC funding
apply as part of a consortium of transnational partners.